awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49152860-20F85975-9025-4937-8238-9448C55C808A
Q49152860-20F85975-9025-4937-8238-9448C55C808A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49152860-20F85975-9025-4937-8238-9448C55C808A
International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.
P2860
Q49152860-20F85975-9025-4937-8238-9448C55C808A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49152860-20F85975-9025-4937-8238-9448C55C808A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d249cbfd9ec0dbb3c0786c16718110b1768ba2c
P2860
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.